Humanized mouse models for organ-specific autoimmune diseases

Current Opinion in Immunology

Volumn 18, Issue 6, 2006, Pages 704-709

  Friese, Manuel A ^a   Jensen, Lise T ^b   Willcox, Nick ^c   Fugger, Lars ^a,b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BRADYKININ B1 RECEPTOR; EPITOPE; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN LIGHT CHAIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; T LYMPHOCYTE RECEPTOR; THYROID PEROXIDASE;

ANEUPLOIDY; ANTIGEN EXPRESSION; ARTHRITIS; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CD8+ T LYMPHOCYTE; CHROMOSOME; DENGUE VIRUS; DISEASE MODEL; DISEASE PREDISPOSITION; EPSTEIN BARR VIRUS; EXPERIMENTAL MODEL; EXPERIMENTAL MOUSE; GENE EXPRESSION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GIANT CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNE DEFICIENCY; IMMUNE SYSTEM; IN VIVO CULTURE; INFLAMMATION; MOUSE STRAIN; NEUROPATHIC PAIN; NONHUMAN; PATHOGENESIS; PSORIASIS; REVIEW; SPECIES COMPARISON; TRANSGENE; TRANSGENIC MOUSE;

ANIMALS; AUTOIMMUNE DISEASES; DISEASE MODELS, ANIMAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MICE; MICE, TRANSGENIC;

EID: 33750969725     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coi.2006.09.003     Document Type: Review

References (54)

1. Jacobson D.L., Gange S.J., Rose N.R., and Graham N.M. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol 84 (1997) 223-243
2. Wade C.M., and Daly M.J. Genetic variation in laboratory mice. Nat Genet 37 (2005) 1175-1180
3. Ransohoff R.M. EAE: pitfalls outweigh virtues of screening potential treatments for multiple sclerosis. Trends Immunol 27 (2006) 167-168
4. Sriram S., and Steiner I. Experimental allergic encephalomyelitis: a misleading model of multiple sclerosis. Ann Neurol 58 (2005) 939-945
5. Friese M.A., Montalban X., Willcox N., Bell J.I., Martin R., and Fugger L. The value of animal models for drug development in multiple sclerosis. Brain 129 (2006) 1940-1952
6. Gold R., Linington C., and Lassmann H. Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. Brain 129 (2006) 1953-1971
7. Roep B.O., Atkinson M., and von Herrath M. Satisfaction (not) guaranteed: re-evaluating the use of animal models of type 1 diabetes. Nat Rev Immunol 4 (2004) 989-997
8. Shoda L.K., Young D.L., Ramanujan S., Whiting C.C., Atkinson M.A., Bluestone J.A., Eisenbarth G.S., Mathis D., Rossini A.A., Campbell S.E., et al. A comprehensive review of interventions in the NOD mouse and implications for translation. Immunity 23 (2005) 115-126
9. Steinman L., and Zamvil S.S. How to successfully apply animal studies in experimental allergic encephalomyelitis to research on multiple sclerosis. Ann Neurol 60 (2006) 12-21
10. Veldhoen M., and Stockinger B. TGFβ1, a 'Jack of all trades': the link with pro-inflammatory IL-17-producing T cells. Trends Immunol 27 (2006) 358-361
11. + T cells in multiple sclerosis: a new target for therapy?. Brain 128 (2005) 1747-1763
12. Gregersen J.W., Holmes S., and Fugger L. Humanized animal models for autoimmune diseases. Tissue Antigens 63 (2004) 383-394
13. Marietta E., Black K., Camilleri M., Krause P., Rogers III R.S., David C., Pittelkow M.R., and Murray J.A. A new model for dermatitis herpetiformis that uses HLA-DQ8 transgenic NOD mice. J Clin Invest 114 (2004) 1090-1097
14. Elliott J.F., Liu J., Yuan Z.N., Bautista-Lopez N., Wallbank S.L., Suzuki K., Rayner D., Nation P., Robertson M.A., Liu G., et al. Autoimmune cardiomyopathy and heart block develop spontaneously in HLA-DQ8 transgenic IAβ knockout NOD mice. Proc Natl Acad Sci USA 100 (2003) 13447-13452
15. Svendsen P., Andersen C.B., Willcox N., Coyle A.J., Holmdahl R., Kamradt T., and Fugger L. Tracking of proinflammatory collagen-specific T cells in early and late collagen-induced arthritis in humanized mice. J Immunol 173 (2004) 7037-7045
16. von Delwig A., Altmann D.M., Isaacs J.D., Harding C.V., Holmdahl R., McKie N., and Robinson J.H. The impact of glycosylation on HLA-DR1-restricted T cell recognition of type II collagen in a mouse model. Arthritis Rheum 54 (2006) 482-491
17. Kim T.H., Uhm W.S., and Inman R.D. Pathogenesis of ankylosing spondylitis and reactive arthritis. Curr Opin Rheumatol 17 (2005) 400-405
18. 2m: an animal model of HLA-B27-associated human disorders. Cell 63 (1990) 1099-1112
19. 2-microglobulin curbs HLA-B27 misfolding and promotes arthritis and spondylitis without colitis in male HLA-B27-transgenic rats. Arthritis Rheum 54 (2006) 1317-1327
20. + T cells in NOD mice. Immunol Rev 204 (2005) 250-263
21. Pinkse G.G., Tysma O.H., Bergen C.A., Kester M.G., Ossendorp F., van Veelen P.A., Keymeulen B., Pipeleers D., Drijfhout J.W., and Roep B.O. Autoreactive CD8 T cells associated with beta cell destruction in type 1 diabetes. Proc Natl Acad Sci USA 102 (2005) 18425-18430
22. Marron M.P., Graser R.T., Chapman H.D., and Serreze D.V. Functional evidence for the mediation of diabetogenic T cell responses by HLA-A2.1 MHC class I molecules through transgenic expression in NOD mice. Proc Natl Acad Sci USA 99 (2002) 13753-13758
23. Takaki T., Marron M.P., Mathews C.E., Guttmann S.T., Bottino R., Trucco M., DiLorenzo T.P., and Serreze D.V. HLA-A*0201-restricted T cells from humanized NOD mice recognize autoantigens of potential clinical relevance to type 1 diabetes. J Immunol 176 (2006) 3257-3265. The authors report important evidence of parallel presentation of a natural auto-epitopes by human and murine pancreatic β cells.
24. + T helper cells as pathogenic effectors.
25. Madsen L.S., Andersson E.C., Jansson L., Krogsgaard M., Andersen C.B., Engberg J., Strominger J.L., Svejgaard A., Hjorth J.P., Holmdahl R., et al. A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor. Nat Genet 23 (1999) 343-347
26. Quandt J.A., Baig M., Yao K., Kawamura K., Huh J., Ludwin S.K., Bian H.J., Bryant M., Quigley L., Nagy Z.A., et al. Unique clinical and pathological features in HLA-DRB1*0401-restricted MBP 111-129-specific humanized TCR transgenic mice. J Exp Med 200 (2004) 223-234
27. Quaratino S., Badami E., Pang Y.Y., Bartok I., Dyson J., Kioussis D., Londei M., and Maiuri L. Degenerate self-reactive human T-cell receptor causes spontaneous autoimmune disease in mice. Nat Med 10 (2004) 920-926
28. Illes Z., Stern J.N., Reddy J., Waldner H., Mycko M.P., Brosnan C.F., Ellmerich S., Altmann D.M., Santambrogio L., Strominger J.L., et al. Modified amino acid copolymers suppress myelin basic protein 85-99-induced encephalomyelitis in humanized mice through different effects on T cells. Proc Natl Acad Sci USA 101 (2004) 11749-11754
29. Illes Z., Stern J.N., Keskin D.B., Reddy J., Brosnan C.F., Waldner H., Santambrogio L., Kuchroo V.K., and Strominger J.L. Copolymer effects on microglia and T cells in the central nervous system of humanized mice. Eur J Immunol 35 (2005) 3683-3693
30. Gladue R.P., Cole S.H., Roach M.L., Tylaska L.A., Nelson R.T., Shepard R.M., McNeish J.D., Ogborne K.T., and Neote K.S. The human specific CCR1 antagonist CP-481,715 inhibits cell infiltration and inflammatory responses in human CCR1 transgenic mice. J Immunol 176 (2006) 3141-3148
31. Charo I.F., and Ransohoff R.M. The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med 354 (2006) 610-621
32. Hess J.F., Chen R.Z., Hey P., Breese R., Chang R.S., Chen T.B., Bock M.G., Vogt T., and Pettibone D.J. Generation and characterization of a humanized bradykinin B1 receptor mouse. Biol Chem 387 (2006) 195-201
33. Marceau F., and Regoli D. Bradykinin receptor ligands: therapeutic perspectives. Nat Rev Drug Discov 3 (2004) 845-852
34. Ma-Krupa W., Jeon M.S., Spoerl S., Tedder T.F., Goronzy J.J., and Weyand C.M. Activation of arterial wall dendritic cells and breakdown of self-tolerance in giant cell arteritis. J Exp Med 199 (2004) 173-183
35. Nestle F.O., Conrad C., Tun-Kyi A., Homey B., Gombert M., Boyman O., Burg G., Liu Y.J., and Gilliet M. Plasmacytoid predendritic cells initiate psoriasis through interferon-α production. J Exp Med 202 (2005) 135-143
36. Macchiarini F., Manz M.G., Palucka A.K., and Shultz L.D. Humanized mice: are we there yet?. J Exp Med 202 (2005) 1307-1311
37. Legrand N., Weijer K., and Spits H. Experimental models to study development and function of the human immune system in vivo. J Immunol 176 (2006) 2053-2058
38. + cells in nonobese diabetic/Shi-scid, IL-2 receptor γ null mice. J Immunol 169 (2002) 204-209
39. null mice model. Blood 102 (2003) 873-880
40. null mice engrafted with mobilized human hemopoietic stem cells. J Immunol 174 (2005) 6477-6489
41. null mice. Blood 106 (2005) 1565-1573
42. Traggiai E., Chicha L., Mazzucchelli L., Bronz L., Piffaretti J.C., Lanzavecchia A., and Manz M.G. Development of a human adaptive immune system in cord blood cell-transplanted mice. Science 304 (2004) 104-107
43. -/- mice: functional inactivation of p53 in developing T cells. Blood 104 (2004) 3886-3893
44. Bente D.A., Melkus M.W., Garcia J.V., and Rico-Hesse R. Dengue fever in humanized NOD/SCID mice. J Virol 79 (2005) 13797-13799
45. Weyand C.M., and Goronzy J.J. Stem cell aging and autoimmunity in rheumatoid arthritis. Trends Mol Med 10 (2004) 426-433
46. Yang L., and Baltimore D. Long-term in vivo provision of antigen-specific T cell immunity by programming hematopoietic stem cells. Proc Natl Acad Sci USA 102 (2005) 4518-4523
47. O'Doherty A., Ruf S., Mulligan C., Hildreth V., Errington M.L., Cooke S., Sesay A., Modino S., Vanes L., Hernandez D., et al. An aneuploid mouse strain carrying human chromosome 21 with Down syndrome phenotypes. Science 309 (2005) 2033-2037. This is a pioneering report that opens new avenues for studying human genes in the context of a murine organism.
48. Rich C., Link J.M., Zamora A., Jacobsen H., Meza-Romero R., Offner H., Jones R., Burrows G.G., Fugger L., and Vandenbark A.A. Myelin oligodendrocyte glycoprotein-35-55 peptide induces severe chronic experimental autoimmune encephalomyelitis in HLA-DR2-transgenic mice. Eur J Immunol 34 (2004) 1251-1261
49. Ito K., Bian H.J., Molina M., Han J., Magram J., Saar E., Belunis C., Bolin D.R., Arceo R., Campbell R., et al. HLA-DR4-IE chimeric class II transgenic, murine class II-deficient mice are susceptible to experimental allergic encephalomyelitis. J Exp Med 183 (1996) 2635-2644
50. Fridkis-Hareli M., Rosloniec E.F., Fugger L., and Strominger J.L. Synthetic amino acid copolymers that bind to HLA-DR proteins and inhibit type II collagen-reactive T cell clones. Proc Natl Acad Sci USA 95 (1998) 12528-12531
51. Rosloniec E.F., Brand D.D., Myers L.K., Whittington K.B., Gumanovskaya M., Zaller D.M., Woods A., Altmann D.M., Stuart J.M., and Kang A.H. An HLA-DR1 transgene confers susceptibility to collagen-induced arthritis elicited with human type II collagen. J Exp Med 185 (1997) 1113-1122
52. Wen L., Chen N.Y., Tang J., Sherwin R., and Wong F.S. The regulatory role of DR4 in a spontaneous diabetes DQ8 transgenic model. J Clin Invest 107 (2001) 871-880
53. Black K.E., Murray J.A., and David C.S. HLA-DQ determines the response to exogenous wheat proteins: a model of gluten sensitivity in transgenic knockout mice. J Immunol 169 (2002) 5595-5600
54. 2m. J Clin Invest 98 (1996) 2746-2755